Immunotherapy of acute myeloid leukemia using Vg9Vd2 T-cells

被引：0
|
作者：
Parente-Pereira, Ana C. [1 ]
Whilding, Lynsey M. [1 ]
Krishnamurthy, Pramila [1 ]
Beatson, Richard [1 ]
Zabinski, Tomasz [1 ]
Barber, Linda [1 ]
Farzaneh, Farzin [1 ]
Mufti, Ghulam [1 ]
Maher, John [1 ]
机构：
[1] Kings Coll London, London, England
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR15-B124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B124
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evolution of Vg9Vd2 T cells
    Karunakaran, M. M.
    Starick, L.
    Goebel, T. W.
    Herrmann, T.
    IMMUNOLOGY, 2012, 137 : 399 - 399
  • [2] TCR and DNAM Dependent Lysis of Acute Monocytic Leukemia (AMoL) by Vg9Vd2 T Lymphocytes.
    Gertner-Dardenne, Julie
    Perrot, Eloise
    Prebet, Thomas
    Charbonnier, Aude
    Sicard, Helene
    Vey, Norbert
    Olive, Daniel
    BLOOD, 2009, 114 (22) : 431 - 431
  • [3] Generation and application of TGFb-educated human Vg9Vd2 T cells
    Parente-Pereira, Ana C.
    Beatson, Richard E.
    Davies, David M.
    Hull, Caroline
    Whilding, Lynsey M.
    Porter, Joanna C.
    Maher, John
    STAR PROTOCOLS, 2022, 3 (02):
  • [4] Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells
    Paniagua-Herranz, Lucia
    Diaz-Tejeiro, Cristina
    Sanvicente, Adrian
    Bartolome, Jorge
    Nieto-Jimenez, Cristina
    Ocana, Alberto
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] IL-18 Reconstitutes Vg9Vd2 T Cells in HIV plus Patient Samples
    Murday, Alanna
    Pauza, C. David
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 : 93 - 93
  • [6] TARGETING BTN2A1 MODULATES ANTI-TUMOR ACTIVITY OF VG9VD2 T CELLS
    Cano, Carla
    de Gassart, Aude
    Pasero, Christine
    Gabriac, Melanie
    Fullana, Marie
    Granarolo, Emilie
    Hoet Rene
    Imbert, Caroline
    Gorvel, Laurent
    Briantais, Antoine
    Le Floch, Anne-Charlotte
    Olive, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A126 - A127
  • [7] Prospects for immunotherapy of acute myeloid leukemia using γδ T cells
    Halim, Leena
    Parente-Pereira, Ana Catarina
    Maher, John
    IMMUNOTHERAPY, 2017, 9 (02) : 111 - 114
  • [8] BSI-093, a best-in-class anti-BTN3A monoclonal antibody for cancer immunotherapy by activation of Vg9Vd2 T cells
    Dai, Wenwen
    Li, Jun
    Liu, Jinyu
    Li, Hongyan
    Liu, Xiaodong F.
    Xia, Shukai
    Lyu, Qun
    Davis, Hugh M.
    Chen, Mingjiu
    Peng, Zeyu
    CANCER RESEARCH, 2024, 84 (06)
  • [9] BTN2A, a New Immune-Checkpoint Targeting Vg9Vd2 T Cell Cytotoxicity
    Cano, Carla E.
    Pasero, Christine
    De Gassart, Aude
    Hoet, Rene
    Scotet, Emmanuel
    Mortier, Erwan
    Quemeneur, Agnes
    Rafia, Chirine
    Briantais, Antoine
    Le Floch, Anne-Charlotte
    Olive, Daniel
    BLOOD, 2019, 134
  • [10] ICT01, AN ANTI-BTN3A MAB THAT ACTIVATES VG9VD2 T CELLS, PLUS INTERLEUKIN-2: A POTENT AND PROMISING COMBINATION FOR CANCER IMMUNOTHERAPY
    de Gassart, Aude
    Brune, Patrick
    Suong, L. E.
    Agaugue, Sophie
    Valentin, Emmanuel
    Sims, Jennifer
    Olive, Daniel
    Frohna, Paul
    Hoet, Rene
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A268 - A269
12345